AbCellera Biologics Inc. ABCL Foreign currency translation
Foreign currency translation at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s foreign currency translation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s foreign currency translation?
- AbCellera Biologics Inc. (ABCL) reported foreign currency translation of $1.82M in Q1 2026.
- How has AbCellera Biologics Inc.'s foreign currency translation changed year-over-year?
- AbCellera Biologics Inc.'s foreign currency translation increased by 169.3% year-over-year, from -$2.62M to $1.82M.
- What does foreign currency translation mean?
- This reflects the net impact of fluctuations in exchange rates on the translation of financial statements from foreign subsidiaries into the reporting currency. It captures unrealized gains or losses that do not flow through the income statement but affect the total equity position. This metric is essential for assessing the company's exposure to international currency volatility.